ArticleAlzheimer's & dementia (New York, N. Y.)

Leveraging recent advances in plasma biomarkers to optimize early proof of concept trials in Alzheimer's disease.

Garrett B Duncan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.